Sonnest, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Sonnest, Inc. - overview
Location
Philadelphia, PA, US
Primary Industry
Medical Devices & Equipment
About
Sonnest, Inc. specializes in providing digital solutions that enhance online presence and streamline business operations for small to medium-sized enterprises, helping them effectively navigate the online landscape. Sonnest, Inc. was founded by Andrew Kohut, Brett Angel, and Michael Cimorelli, with Josh White serving as the CEO.
The company is headquartered in Philadelphia, US, and focuses on digital services tailored for SMEs. In May 2021, Sonnest, Inc. raised USD 4 mn in Series A funding, led by Robin Hood Ventures, SWAN Impact, and Texas Halo Fund. Sonnest, Inc.
offers a comprehensive suite of digital solutions, including web hosting services, domain registration, and website building tools. These offerings are designed to assist small to medium-sized enterprises in establishing their digital presence, addressing website accessibility, online marketing, and customer engagement issues. The company serves a broad client base, including entrepreneurs, small business owners, and e-commerce operators across North America, Europe, and Asia-Pacific regions. Sonnest, Inc.
generates revenue through a structured model that combines subscription services and one-time fees. Clients typically subscribe to annual or monthly web hosting and related services, with optional add-ons such as premium support. The firm operates a direct-to-consumer model, allowing customers to purchase services from its website, with flagship products including web hosting packages and domain registration services offered at tiered pricing levels to accommodate diverse customer needs. Following the Series A funding round in May 2021, Sonnest, Inc.
intends to utilize the USD 4 mn raised to advance its product offerings, specifically the Electrast™ technology. The company aims to move Electrast™ into clinical settings, focusing on confirming its safety profile and generating proof-of-principle ultrasound images in human patients, akin to previous demonstrations in other animal models. These initiatives are part of Sonnest's strategy to enhance its product lineup and expand its market reach.
Current Investors
Robin Hood Ventures, Texas Halo Fund, SWAN Impact
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic Equipment
Website
www.sonnest.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Sonnest, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.